Singhal Anil K. has filed 4 insider transactions across 2 companies since August 2024.
Most recent transaction: a grant/award of 9000 shares of Werewolf Therapeutics, Inc. ($HOWL) on June 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | Werewolf Therapeutics, Inc. | $HOWL | Singhal Anil K. | Not found | A | Stock Option (right to buy) | 9000 | $0.00 | 9,000.0000 | 44,827,159 | 9999.99% | 0.02% |
| June 12, 2025 | Werewolf Therapeutics, Inc. | $HOWL | Singhal Anil K. | Not found | A | Stock Option (right to buy) | 8358 | $0.00 | 8,358.0000 | 44,827,159 | 9999.99% | 0.02% |
| Feb. 19, 2025 | Werewolf Therapeutics, Inc. | $HOWL | Singhal Anil K. | Not found | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Singhal Anil K. | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |